MD266C2 - Process for preparation of 5-haloid thienoisothiazole-3(2H)-on-1,1-dioxides derivatives - Google Patents
Process for preparation of 5-haloid thienoisothiazole-3(2H)-on-1,1-dioxides derivativesInfo
- Publication number
- MD266C2 MD266C2 MD94-0300A MD940300A MD266C2 MD 266 C2 MD266 C2 MD 266C2 MD 940300 A MD940300 A MD 940300A MD 266 C2 MD266 C2 MD 266C2
- Authority
- MD
- Moldova
- Prior art keywords
- haloid
- dioxides
- derivatives
- preparation
- formulawhere
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 230000000949 anxiolytic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
The invention relates to the heterocyclic materials and, particularly, to the preparation of the 5-haloid theienoisothiazoles-3-(2H)-on-1,1-dioxides derivatives or pharmaceutically supportable acidic additive salts of formulawhere R is haloid, possessing the anxiolytic activity, which may be used in the medicine.The aim of the invention - cleation of new more active substances of the indicated class. the syntehesis is conductes by the reaction of 1-(2-pyrimidinylpiperazine with the compound of formulawhere X - haloid in the absolute dimetilhylformamide medium at 60°C during 45 min at further desired product isolation in the free form or in the form of the required salt. The new materials are low-toxic (more then 2000 mg/kg) and possesse a high antxiolytic activity.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT88390A ATA39088A (en) | 1988-02-18 | 1988-02-18 | BASICALLY SUBSTITUTED THIENOISOTHIAZOL-3 (2H) -ON-1,1-DIOXIDES AND THEIR PHARMACEUTICALLY COMPATIBLE SALTS, METHOD FOR THE PRODUCTION AND THEIR USE |
| SU894613473A SU1729293A3 (en) | 1988-02-18 | 1989-02-17 | Method for preparation derivatives of 5-haloid tienoisothiazole-3 (2 h)-oh-1,1 dioxides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD266B1 MD266B1 (en) | 1995-08-31 |
| MD266C2 true MD266C2 (en) | 1995-12-31 |
Family
ID=25592550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MD94-0300A MD266C2 (en) | 1988-02-18 | 1994-09-14 | Process for preparation of 5-haloid thienoisothiazole-3(2H)-on-1,1-dioxides derivatives |
Country Status (2)
| Country | Link |
|---|---|
| LV (1) | LV5521A3 (en) |
| MD (1) | MD266C2 (en) |
-
1993
- 1993-11-17 LV LV931251A patent/LV5521A3/en unknown
-
1994
- 1994-09-14 MD MD94-0300A patent/MD266C2/en not_active IP Right Cessation
Non-Patent Citations (1)
| Title |
|---|
| Brevet nr. 0220051, EP, Int. cl. C 07 D 417/14, 1987. * |
Also Published As
| Publication number | Publication date |
|---|---|
| LV5521A3 (en) | 1994-03-10 |
| MD266B1 (en) | 1995-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY101268A (en) | Naphthalene derivatives, process for the preparation thereof and pharmaceutical composition containing same | |
| NZ228016A (en) | Substituted piperazine derivatives and pharmaceutical derivatives thereof | |
| HUT53368A (en) | Process for producing pyrazolo-pyridine derivatives and pharmaceutical compositions containing them | |
| ES8403905A1 (en) | Piperazines and homopiperazines, N-substituted by an aromatic heterocyclic group, and their use in therapeutics | |
| EP0223385A3 (en) | 8-azabicycloû3,2,1¨octane and 9-azabicycloû3,3,1¨nonane derivatives | |
| HUT51601A (en) | Process for production of new derivatives of imidasoline and medical compositions containing them as active substance | |
| PT77370A (en) | Process for preparing new pyrazolo <3,4-b> piridine derivatives and pharmaceutical preparations containing the same | |
| HUT46895A (en) | Process for production of new 5-lipoxigenase bicyclic compounds with inhibiation effect | |
| EP0591529A4 (en) | NEW BENZODIAZEPINE DERIVATIVE. | |
| HUT45081A (en) | Process for producing amino acid derivatives and pharmaceuticals comprising these compounds as active ingredient | |
| MD266C2 (en) | Process for preparation of 5-haloid thienoisothiazole-3(2H)-on-1,1-dioxides derivatives | |
| HU896174D0 (en) | Process for the preparation of heterocyclic derivatives fusionated 1,2,3,4-tetrahydro-acridine and pharmaceutical compositions thereof | |
| FI893570A0 (en) | Process for the preparation of 1H-imidazo [1,2-b] pyrazole derivatives useful as medicaments | |
| HUT51622A (en) | Process for producing 3-piperidinole-indazole derivatives and pharmaceutical preparations having effect against high blood pressure containing these compounds as active substance | |
| HUT49110A (en) | Process for producing ether derivatives and thioether derivatives, as well as pharmaceutical compositions comprising these compounds as active ingredient | |
| ES8104265A1 (en) | Benzenesulfinamides, a process for the preparation thereof and medicaments containing them. | |
| AU6683186A (en) | 6H-isoxazolo`` 3,4-d`` pyrazolo`` 3,4-b`` pyridines,a process for their preparation and their use as medicaments | |
| GB1505859A (en) | Azetidinone derivatives | |
| ES479804A1 (en) | Clavulanic acid derivatives, preparation and compositions. | |
| PT78689A (en) | Process for preparing beta-lactamase inhibiting 6-(alkoxyaminomethyl)penicillanic acid 1,1-dioxide and derivatives | |
| ES8506637A1 (en) | (5-(2-Aminomethyl-imidazol-1-yl)-1,3-dialkyl-1H-pyrazol-4-yl)(aryl)methanones and processes for their production. | |
| EP0231124A3 (en) | Cephalosporin derivatives, salts thereof, process for their manufacture, and pharmaceutical agents comprising them | |
| HUT51614A (en) | Process for producing cardio-protective and suitable for treating ischemic illnesses pharmaceutical compositions containing nitriferous heterocyclic compounds as active agent as well as for producing the active agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 1M4A | Expiration of terms |